Join
Live feed
·
PRReleasevia Quantisnow
Bristol-Myers Squibb Company logo
Tempus AI Inc. logo

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

ByQuantisnow·Wall Street's wire, on your screen.
BMY· Bristol-Myers Squibb CompanyTEM· Tempus AI Inc.
Health CareTechnology

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BMY (Bristol-Myers Squibb Company), TEM (Tempus AI Inc.) and more on Quantisnow.

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience | Quantisnow